Arbutus Biopharma Corp

ABUSNASDAQ
$5.08
0.030.59%
Last update: Sep 17, 7:59 AM

Arbutus Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Arbutus Biopharma (ABUS).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

1S.Buy
3Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$6Upside to Avg. PT+8.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings
DateFirmAnalystActionRating ChangePrice Target
Nov 14, 2025Chardan CapitalKeay NakaeMaintainedBuy$5
Aug 11, 2025Chardan CapitalKeay NakaeMaintainedBuy$5